$ASND announced it received a CRL on 4/28/23

CATALYST

Summary:

First posted 3/14/2023; last updated 4/3/23

Summary:

$XBI $72.60 | +4.94% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX 0.0% (+22% AH) Novavax...

$XBI $72.60 | +4.94% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX 0.0% (+22% AH) Novavax...

At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...

At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...

The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...

We eagerly await Ascendis's (ASND) imminent phase 3 top-line results for its weekly growth hormone therapeutic candidate, TransCon GH....